Identification of m6A-Related Biomarkers in Systemic Lupus Erythematosus: A Bioinformation-Based Analysis

References

• Tsokos GC, Lo MS, Costa Reis P, et al. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2016;12(12):716–730. doi:10.1038/nrrheum.2016.186
   PubMed Web of Science ®Google Scholar
• Crow MK. Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Ann Rheum Dis. 2023;82(8):999–1014. doi:10.1136/ard-2022-223741
   PubMed Web of Science ®Google Scholar
• Roundtree IA, Evans ME, Pan T, et al. Dynamic RNA modifications in gene expression regulation. Cell. 2017;169(7):1187–1200. doi:10.1016/j.cell.2017.05.045
   PubMed Web of Science ®Google Scholar
• Cui L, Ma R, Cai J, et al. RNA modifications: importance in immune cell biology and related diseases. Signal Transduct Target Ther. 2022;7(1):334. doi:10.1038/s41392-022-01175-9
   PubMed Web of Science ®Google Scholar
• Zhao X, Ge L, Wang J, et al. Exploration of potential integrated models of N6-methyladenosine immunity in systemic lupus erythematosus by bioinformatic analyses. Front Immunol. 2021;12:752736. doi:10.3389/fimmu.2021.752736
   PubMed Web of Science ®Google Scholar
• Huang Y, Xue Q, Chang J, et al. M6A methylation modification in autoimmune diseases, a promising treatment strategy based on epigenetics. Arthritis Res Ther. 2023;25(1):189. doi:10.1186/s13075-023-03149-w
   PubMed Web of Science ®Google Scholar
• Li LJ, Fan YG, Leng RX, et al. Potential link between m(6)A modification and systemic lupus erythematosus. Mol Immunol. 2018;93:55–63. doi:10.1016/j.molimm.2017.11.009
   PubMed Web of Science ®Google Scholar
• Lv X, Liu X, Zhao M, et al. RNA methylation in systemic lupus erythematosus. Front Cell Dev Biol. 2021;9:696559. doi:10.3389/fcell.2021.696559
   PubMed Web of Science ®Google Scholar
• Lu S, Wei X, Zhu H, et al. m(6)A methyltransferase METTL3 programs CD4(+) T-cell activation and effector T-cell differentiation in systemic lupus erythematosus. Mol Med. 2023;29(1):46. doi:10.1186/s10020-023-00643-4
   PubMed Web of Science ®Google Scholar
• Zhao X, Dong R, Zhang L, et al. N6-methyladenosine-dependent modification of circGARS acts as a new player that promotes SLE progression through the NF-κB/A20 axis. Arthritis Res Ther. 2022;24(1):37. doi:10.1186/s13075-022-02732-x
   PubMed Web of Science ®Google Scholar
• Wu J, Deng L-J, Xia Y-R, et al. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus. Mol Immunol. 2022;143:77–84. doi:10.1016/j.molimm.2022.01.006
   PubMed Web of Science ®Google Scholar
• Zhou W, Wang X, Chang J, et al. The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases. Crit Rev Clin Lab Sci. 2022;59(3):203–218. doi:10.1080/10408363.2021.2002256
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41(Database issue):D991–D995. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Law CW, Chen Y, Shi W, et al. voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29. doi:10.1186/gb-2014-15-2-r29
   PubMed Web of Science ®Google Scholar
• Kolde R, Laur S, Adler P, et al. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics. 2012;28(4):573–580. doi:10.1093/bioinformatics/btr709
   PubMed Web of Science ®Google Scholar
• Leek JT, Johnson WE, Parker HS, et al. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–883. doi:10.1093/bioinformatics/bts034
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Liberzon A, Birger C, Thorvaldsdóttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Systems. 2015;1(6):417–425. doi:10.1016/j.cels.2015.12.004
   PubMed Web of Science ®Google Scholar
• Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. doi:10.1093/nar/gkv007
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27–30. doi:10.1093/nar/28.1.27
   PubMed Web of Science ®Google Scholar
• Liaw A, Wiener MC. Classification and regression by randomforest. R News. 2002;2(3):18–22.
   Google Scholar
• Harrell JFE. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001.
   Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf. 2008;9(1):559. doi:10.1186/1471-2105-9-559
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. Fast R functions for robust correlations and hierarchical clustering. J Stat Softw. 2012;46(11). doi:10.18637/jss.v046.i11
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14(1):7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinf. 2011;12(1):77. doi:10.1186/1471-2105-12-77
   PubMed Web of Science ®Google Scholar
• Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141. doi:10.1016/j.xinn.2021.100141
   Web of Science ®Google Scholar
• Li HB, Tong J, Zhu S, et al. m(6)A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways. Nature. 2017;548(7667):338–342. doi:10.1038/nature23450
   PubMed Web of Science ®Google Scholar
• Dong L, Chen C, Zhang Y, et al. The loss of RNA N(6)-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8(+) T cell dysfunction and tumor growth. Cancer Cell. 2021;39(7):945–57.e10. doi:10.1016/j.ccell.2021.04.016
   PubMed Web of Science ®Google Scholar
• Ito-Kureha T, Leoni C, Borland K, et al. The function of Wtap in N(6)-adenosine methylation of mRNAs controls T cell receptor signaling and survival of T cells. Nat Immunol. 2022;23(8):1208–1221. doi:10.1038/s41590-022-01268-1
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhang L, Cui XL, et al. Control of early B cell development by the RNA N(6)-methyladenosine methylation. Cell Rep. 2020;31(13):107819. doi:10.1016/j.celrep.2020.107819
   PubMed Web of Science ®Google Scholar
• Han D, Liu J, Chen C, et al. Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells. Nature. 2019;566(7743):270–274. doi:10.1038/s41586-019-0916-x
   PubMed Web of Science ®Google Scholar
• Wang H, Hu X, Huang M, et al. Mettl3-mediated mRNA m(6)A methylation promotes dendritic cell activation. Nat Commun. 2019;10(1):1898. doi:10.1038/s41467-019-09903-6
   PubMed Web of Science ®Google Scholar
• Zhou MJ, Liu W, Zhang JY, et al. RNA m(6)A modification in immunocytes and DNA repair: the biological functions and prospects in clinical application. Front Cell Develop Biol. 2021;9:13. doi:10.3389/fcell.2021.794754
   Web of Science ®Google Scholar
• Sciascia S, Roccatello D, Radin M, et al. Differentiating between UCTD and early-stage SLE: from definitions to clinical approach. Nat Rev Rheumatol. 2022;18(1):9–21. doi:10.1038/s41584-021-00710-2
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhou Y, Zhu B, et al. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis. 2016;75(11):1998–2006. doi:10.1136/annrheumdis-2015-208410
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang L, Wang J, et al. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis. J Transl Med. 2021;19(1):35. doi:10.1186/s12967-020-02698-x
   PubMed Web of Science ®Google Scholar
• Shen L, Lan L, Zhu T, et al. Identification and validation of IFI44 as key biomarker in lupus nephritis. Front Med Lausanne. 2021;8:762848. doi:10.3389/fmed.2021.762848
   PubMed Web of Science ®Google Scholar
• Zheng Q, Wang D, Lin R, et al. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Front Immunol. 2022;13:1013322. doi:10.3389/fimmu.2022.1013322
   PubMedGoogle Scholar
• Jiang Z, Shao M, Dai X, et al. Identification of diagnostic biomarkers in systemic lupus erythematosus based on bioinformatics analysis and machine learning. Front Genet. 2022;13:865559. doi:10.3389/fgene.2022.865559
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang Z, Xiao Y, et al. The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis. Front Immunol. 2022;13:1015882. doi:10.3389/fimmu.2022.1015882
   PubMed Web of Science ®Google Scholar
• Liu C, Zhou Y, Zhou Y, et al. Identification of crucial genes for predicting the risk of atherosclerosis with system lupus erythematosus based on comprehensive bioinformatics analysis and machine learning. Comput Biol Med. 2023;152:106388. doi:10.1016/j.compbiomed.2022.106388
   PubMed Web of Science ®Google Scholar
• Li H, Zhang X, Shang J, et al. Identification of NETs-related biomarkers and molecular clusters in systemic lupus erythematosus. Front Immunol. 2023;14:1150828. doi:10.3389/fimmu.2023.1150828
   PubMed Web of Science ®Google Scholar
• Kapadia M, Zhao H, Ma D, et al. Sustained immunosuppression alters olfactory function in the MRL model of CNS lupus. J Neuroimmune Pharmacol. 2017;12(3):555–564. doi:10.1007/s11481-017-9745-6
   PubMed Web of Science ®Google Scholar
• Bombini MF, Peres FA, Lapa AT, et al. Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature. Autoimmun Rev. 2018;17(4):405–412. doi:10.1016/j.autrev.2018.02.002
   PubMed Web of Science ®Google Scholar
• Bao X, Zhang Y, Li H, et al. RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications. Nucleic Acids Res. 2023;51(D1):D269–D279. doi:10.1093/nar/gkac945
   PubMed Web of Science ®Google Scholar
• Faber-Elmann A, Sthoeger Z, Tcherniack A, et al. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol. 2002;127(2):393–398. doi:10.1046/j.1365-2249.2002.01758.x
   PubMed Web of Science ®Google Scholar
• de Almeida LGN, Thode H, Eslambolchi Y, et al. Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev. 2022;74(3):712–768. doi:10.1124/pharmrev.121.000349
   PubMed Web of Science ®Google Scholar
• Ugarte-Berzal E, Boon L, Martens E, et al. MMP-9/gelatinase B degrades immune complexes in systemic lupus erythematosus. Front Immunol. 2019;10:538. doi:10.3389/fimmu.2019.00538
   PubMed Web of Science ®Google Scholar
• Carmona-Rivera C, Zhao W, Yalavarthi S, et al. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis. 2015;74(7):1417–1424. doi:10.1136/annrheumdis-2013-204837
   PubMed Web of Science ®Google Scholar
• Phillips TM, Fadia M, Lea-Henry TN, et al. MMP2 and MMP9 associate with crescentic glomerulonephritis. Clin Kidney J. 2017;10(2):215–220. doi:10.1093/ckj/sfw111
   PubMed Web of Science ®Google Scholar
• Jiang Z, Sui T, Wang B. Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis. Rheumatol Int. 2010;30(9):1219–1226. doi:10.1007/s00296-009-1135-9
   PubMed Web of Science ®Google Scholar
• Beroun A, Mitra S, Michaluk P, et al. MMPs in learning and memory and neuropsychiatric disorders. Cell Mol Life Sci. 2019;76(16):3207–3228. doi:10.1007/s00018-019-03180-8
   PubMed Web of Science ®Google Scholar
• Vafadari B, Salamian A, Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J Neurochem. 2016;139(Suppl 2):91–114. doi:10.1111/jnc.13415
   PubMedGoogle Scholar
• Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci. 2016;10:56. doi:10.3389/fncel.2016.00056
   PubMed Web of Science ®Google Scholar
• Yafasova A, Fosbøl EL, Schou M, et al. Long-term cardiovascular outcomes in systemic lupus erythematosus. J Am Coll Cardiol. 2021;77(14):1717–1727. doi:10.1016/j.jacc.2021.02.029
   PubMed Web of Science ®Google Scholar
• Gao N, Kong M, Li X, et al. Systemic lupus erythematosus and cardiovascular disease: a Mendelian randomization study. Front Immunol. 2022;13:908831. doi:10.3389/fimmu.2022.908831
   PubMedGoogle Scholar
• Tektonidou MG, Wang Z, Ward MM. Brief report: trends in hospitalizations due to acute coronary syndromes and stroke in patients with systemic lupus erythematosus, 1996 to 2012. Arthritis Rheumatol. 2016;68(11):2680–2685. doi:10.1002/art.39758
   PubMed Web of Science ®Google Scholar
• Shaban A, Leira EC. Neurological complications in patients with systemic lupus erythematosus. Curr Neurol Neurosci Rep. 2019;19(12):97. doi:10.1007/s11910-019-1012-1
   PubMed Web of Science ®Google Scholar
• Di Biase L, Bonura A, Pecoraro PM, et al. Unlocking the potential of stroke blood biomarkers: early diagnosis, ischemic vs. haemorrhagic differentiation and haemorrhagic transformation risk: a comprehensive review. Int J Mol Sci. 2023;24(14):11545. doi:10.3390/ijms241411545
   PubMed Web of Science ®Google Scholar
• Chaturvedi M, Kaczmarek L. MMP-9 inhibition: a therapeutic strategy in ischemic stroke. Mol Neurobiol. 2014;49(1):563–573. doi:10.1007/s12035-013-8538-z
   PubMed Web of Science ®Google Scholar
• Jickling GC, Liu D, Stamova B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34(2):185–199. doi:10.1038/jcbfm.2013.203
   PubMed Web of Science ®Google Scholar
• Wen D, Du X, Nie S-P, et al. Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis. Mol Neurobiol. 2014;50(3):979–985. doi:10.1007/s12035-014-8687-8
   PubMed Web of Science ®Google Scholar
• Misra S, Talwar P, Kumar A, et al. Association between matrix metalloproteinase family gene polymorphisms and risk of ischemic stroke: a systematic review and meta-analysis of 29 studies. Gene. 2018;672:180–194. doi:10.1016/j.gene.2018.06.027
   PubMed Web of Science ®Google Scholar
• Buraczynska K, Kurzepa J, Ksiazek A, et al. Matrix Metalloproteinase-9 (MMP-9) gene polymorphism in stroke patients. Neuromolecular Med. 2015;17(4):385–390. doi:10.1007/s12017-015-8367-5
   PubMed Web of Science ®Google Scholar
• Fan D, Zheng C, Wu W, et al. MMP9 SNP and MMP SNP-SNP interactions increase the risk for ischemic stroke in the Han Hakka population. Brain Behav. 2022;12(2):e2473.
   PubMed Web of Science ®Google Scholar
• Zhong C, Yang J, Xu T, et al. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke. Neurology. 2017;89(8):805–812. doi:10.1212/WNL.0000000000004257
   PubMed Web of Science ®Google Scholar
• Zhong C, Bu X, Xu T, et al. Serum matrix metalloproteinase-9 and cognitive impairment after acute ischemic stroke. J Am Heart Assoc. 2018;7(1):e007776.
   PubMed Web of Science ®Google Scholar
• Zhang M, Meng X, Pan Y, et al. Predictive values of baseline matrix metalloproteinase 9 levels in peripheral blood on 3-month outcomes of high-risk patients with minor stroke or transient ischemic attack. Eur J Neurol. 2022;29(10):2976–2986. doi:10.1111/ene.15342
   PubMed Web of Science ®Google Scholar
• Wang J, Liu R, Hasan MN, et al. Role of SPAK-NKCC1 signaling cascade in the choroid plexus blood-CSF barrier damage after stroke. J Neuroinflammation. 2022;19(1):91. doi:10.1186/s12974-022-02456-4
   PubMed Web of Science ®Google Scholar
• Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318(19):1925–1926. doi:10.1001/jama.2017.17219
   PubMed Web of Science ®Google Scholar
• Hartwig FP, Davies NM, Hemani G, et al. Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique. Int J Epidemiol. 2016;45(6):1717–1726. doi:10.1093/ije/dyx028
   PubMed Web of Science ®Google Scholar